Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|11|1|22-34

ISSN： 1574-8863

Source： Current Drug Safety, Vol.11, Iss.1, 2016-03, pp. : 22-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 12-21

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 44-46

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 47-54

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Psoriasis: Safety Profile

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 4-11

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta‐Analysis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 1, 2015-01 ,pp. : 117-127

John Wiley & Sons Inc

Access to resources Recommend Favorite